1-3 of 3
Bin Gu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Reduced-Dose Chemotherapy Followed By Blinatumomab As Induction Therapy in Treatment of Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia - Interim Results from a Multicenter, Single-Arm, Phase 2 Study

Jing Lu, Ying Wang, Huiying Qiu, Xin Zhou, Xuzhang Lu, Miao Miao, Bin Gu, Xiaohui Hu, Depei Wu, Suning Chen
Journal: Blood
Blood (2023) 142 (Supplement 1): 4243.
https://doi.org/10.1182/blood-2023-174831
Published: 2023
Journal Articles

Bortezomib and High-Dose Melphalan as a Novel Conditioning Regimen for Patients with POEMS Syndrome Undergoing Autologous Peripheral Blood Stem Cell Transplantation.

XiaoWen Tang, MD, Xiaolan Shi, Xiaohui Hu, Shengli Xue, Huiying Qiu, Yue Han, Lingzhi Yan, Huifen Zhou, Yuejun Liu, Bin Gu, Aining Sun, Wu Depei, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4599.
https://doi.org/10.1182/blood.V116.21.4599.4599
Published: 2010
Journal Articles

Successful Bortezomib-Based Therapy in POEMS Syndrome.

Xiaowen Tang, Xiaolan Shi, Aining Sun, Huiying Qiu, Bin Gu, Huifen Zhou, Shengli Xue, Yuejun Liu, Changgeng Ruan, Wu Depei
Journal: Blood
Blood (2009) 114 (22): 4966.
https://doi.org/10.1182/blood.V114.22.4966.4966
Published: 2009